Ingram 2020 MitoFit Preprint Arch: Difference between revisions
No edit summary |
No edit summary  |
||
(6 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{MitoFit page name}} | {{MitoFit page name}} | ||
{{Publication | {{Publication | ||
|title=Ingram TL, Shephard F, Sarmad S, Ortori CA, Barrett DA | |title=Ingram TL, Shephard F, Sarmad S, Ortori CA, Barrett DA, Chakrabarti L (2020) Sex differences characterise inflammatory profiles of cerebellar mitochondria and are attenuated in Parkinsonâs disease. https://doi.org/10.26124/mitofit:200002 | ||
|info=[[File:MitoFit Preprint Arch pdf.png|left|160px|link=https://wiki.oroboros.at/images/7/70/Ingram_et_al._2020_MitoFit_Preprint_Arch.pdf|MitoFit pdf]] | |info=MitoFit Preprint Arch 2020.2 [[File:MitoFit Preprint Arch pdf.png|left|160px|link=https://wiki.oroboros.at/images/7/70/Ingram_et_al._2020_MitoFit_Preprint_Arch.pdf|MitoFit pdf]] '''[https://wiki.oroboros.at/images/7/70/Ingram_et_al._2020_MitoFit_Preprint_Arch.pdf Sex differences characterise inflammatory profiles of cerebellar mitochondria and are attenuated in Parkinsonâs disease.]''' - | ||
|authors=Thomas L | |authors=Ingram Thomas L, Shephard Freya, Sarmad Sarir, Ortori Catherine A, Barrett David A, Chakrabarti Lisa | ||
|year=2020 | |year=2020 | ||
|journal=MitoFit Preprint Arch | |journal=MitoFit Preprint Arch |
Latest revision as of 08:18, 8 January 2023
Ingram 2020 MitoFit Preprint Arch
Ingram TL, Shephard F, Sarmad S, Ortori CA, Barrett DA, Chakrabarti L (2020) Sex differences characterise inflammatory profiles of cerebellar mitochondria and are attenuated in Parkinsonâs disease. https://doi.org/10.26124/mitofit:200002 |
» MitoFit Preprint Arch 2020.2
Ingram Thomas L, Shephard Freya, Sarmad Sarir, Ortori Catherine A, Barrett David A, Chakrabarti Lisa (2020) MitoFit Preprint Arch
Abstract: Version 1 (v1) 2020-04-30 doi:10.26124/mitofit:200002
Response to inflammation is a key determinant in many diseases and their outcomes. Diseases that commonly affect older people are frequently associated with altered inflammatory processes. Neuroinflammation has been described in Parkinsonâs disease (PD) brain and presents a potential therapeutic target. PD is characterised by the loss of dopaminergic neurons in the substantia nigra pars compacta and at the sub-cellular level, mitochondrial dysfunction is a key feature. However, there is evidence that a different region of the brain, the cerebellum, is involved in the pathophysiology of PD. We report relative levels of 40 pro- and anti-inflammatory cytokines measured in PD and control cerebellar mitochondria. These data were obtained by screening cytokine antibody arrays. In parallel, we present concentrations of 29 oxylipins and 4 endocannabinoids measured in mitochondrial fractions isolated from post-mortem PD cerebellum with age and sex matched controls. Our oxylipin and endocannabinoid data were acquired via quantitation by LC-ESI--MS/MS. The separate sample sets both show there are clearly different inflammatory profiles between the sexes in control samples. Sex specific profiles were not maintained in cerebellar mitochondria isolated from PD brains. One interpretation of our findings is that normally females have a wide-ranging inflammatory profile that can respond to or absorb the effects of increased levels of cytokines and oxylipins. These observations may have implications for other inflammatory diseases where the sexes are affected unequally in number or severity. âą Keywords: Inflammation, Parkinson's disease, cerebellar mitochondria, sex differences âą Bioblast editor: Iglesias-Gonzalez J
Figures
References
- Alafuzoff, I. et al. (2009) âStaging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.â, Acta neuropathologica, 117(6), pp. 635â52. doi: 10.1007/s00401-009-0523-2.
- Area-Gomez, E. et al. (2019) âMitochondria, OxPhos, and neurodegeneration: Cells are not just running out of gasâ, Journal of Clinical Investigation. American Society for Clinical Investigation. doi: 10.1172/JCI120848.
- Balgoma, D. et al. (2013) âQuantitative metabolic profiling of lipid mediatorsâ, Molecular Nutrition & Food Research, 57(8), pp. 1359â1377. doi: 10.1002/mnfr.201200840.
- Blesa, J. et al. (2017) âCompensatory mechanisms in Parkinsonâs disease: Circuits adaptations and role in disease modificationâ, Experimental Neurology. Academic Press Inc., pp. 148â161. doi: 10.1016/j.expneurol.2017.10.002.
- Bose, A. and Beal, M. F. (2016) âMitochondrial dysfunction in Parkinsonâs diseaseâ, Journal of Neurochemistry, 139, pp. 216â231. doi: 10.1111/jnc.13731.
- Caligiuri, S. P. B. et al. (2017) âDietary modulation of oxylipins in cardiovascular disease and agingâ, American Journal of Physiology-Heart and Circulatory Physiology, 313(5), pp. H903âH918. doi: 10.1152/ajpheart.00201.2017.
- Caranci, G. et al. (2013) âGender differences in Parkinsonâs disease: focus on plasma α-synuclein.â, Journal of neural transmission (Vienna, AustriaâŻ: 1996), 120(8), pp. 1209â15. doi: 10.1007/s00702-013-0972-6.
- Chandra, G. et al. (2016) âNeutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Diseaseâ, Journal of Biological Chemistry, 291(29), pp. 15267â15281. doi: 10.1074/jbc.M116.714824.
- Chen, W. et al. (2019) âGender differences in prevalence of LRRK2-associated Parkinson diseaseïŒA meta-analysis of observational studies.â, Neuroscience letters, p. 134609. doi: 10.1016/j.neulet.2019.134609.
- Dewing, P. et al. (2006) âDirect regulation of adult brain function by the male-specific factor SRYâ, Current Biology. Curr Biol, 16(4), pp. 415â420. doi: 10.1016/j.cub.2006.01.017.
- Dexter, D. T. et al. (1989) âBasal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinsonâs Diseaseâ, Journal of Neurochemistry. John Wiley & Sons, Ltd (10.1111), 52(2), pp. 381â389. doi: 10.1111/j.1471-4159.1989.tb09133.x.
- Dirkx, M. F. et al. (2019) âCerebral differences between dopamine-resistant and dopamine-responsive Parkinsonâs tremorâ, Brain, 142(10), pp. 3144â3157. doi: 10.1093/brain/awz261.
- Eikelenboom, P. et al. (2010) âNeuroinflammation - An early event in both the history and pathogenesis of Alzheimerâs diseaseâ, in Neurodegenerative Diseases. Neurodegener Dis, pp. 38â41. doi: 10.1159/000283480.
- Erickson, M. A. et al. (2018) âGenetics and sex influence peripheral and central innate immune responses and blood-brain barrier integrityâ, PLOS ONE. Edited by D. Janigro, 13(10), p. e0205769. doi: 10.1371/journal.pone.0205769.
- Ferdouse, A. et al. (2019) âThe Brain Oxylipin Profile Is Resistant to Modulation by Dietary n-6 and n-3 Polyunsaturated Fatty Acids in Male and Female Ratsâ, Lipids. John Wiley and Sons Inc., 54(1), pp. 67â80. doi: 10.1002/lipd.12122.
- Fischer, R. et al. (2011) âA TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell deathâ, PLoS ONE. PLoS One, 6(11). doi: 10.1371/journal.pone.0027621.
- De Franceschi, G. et al. (2017) âα-Synuclein structural features inhibit harmful polyunsaturated fatty acid oxidation, suggesting roles in neuroprotectionâ, Journal of Biological Chemistry, 292(17), pp. 6927â6937. doi: 10.1074/jbc.M116.765149.
- Garwood, C. J. et al. (2010) âAnti-inflammatory impact of minocycline in a mouse model of tauopathyâ, Frontiers in Psychiatry. Front Psychiatry, 1(OCT). doi: 10.3389/fpsyt.2010.00136.
- Giuliani, N. et al. (2001) âSerum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changesâ, Experimental Gerontology, 36(3), pp. 547â557. doi: 10.1016/S0531-5565(00)00220-5.
- Goodfellow, P. N. and Lovell-Badge, R. (1993) âSRY and Sex Determination in Mammalsâ, Annual Review of Genetics. Annual Reviews, 27(1), pp. 71â92. doi: 10.1146/annurev.ge.27.120193.000443.
- Guzman-Martinez, L. et al. (2019) âNeuroinflammation as a Common Feature of Neurodegenerative Disordersâ, Frontiers in Pharmacology, 10, p. 1008. doi: 10.3389/fphar.2019.01008.
- Haque, M. E. et al. (2019) âTargeting the microglial NLRP3 inflammasome and its role in Parkinsonâs diseaseâ, Movement Disorders, p. mds.27874. doi: 10.1002/mds.27874.
- Hazeldine, J. et al. (2019) âTraumatic Injury and Exposure to Mitochondrial-Derived Damage Associated Molecular Patterns Suppresses Neutrophil Extracellular Trap Formationâ, Frontiers in Immunology, 10, p. 685. doi: 10.3389/fimmu.2019.00685.
- Kang, K. H. et al. (2013) âProtection of dopaminergic neurons by 5-lipoxygenase inhibitorâ, Neuropharmacology. Elsevier Ltd, 73, pp. 380â387. doi: 10.1016/j.neuropharm.2013.06.014.
- Kauppila, T. E. S., Kauppila, J. H. K. and Larsson, N. G. (2017) âMammalian Mitochondria and Aging: An Updateâ, Cell Metabolism. Cell Press, pp. 57â71. doi: 10.1016/j.cmet.2016.09.017.
- Kaut, O. et al. (2019) â5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinsonâs diseaseâ, Journal of Chemical Neuroanatomy. Elsevier B.V., 96, pp. 41â48. doi: 10.1016/j.jchemneu.2018.12.005.
- Krashia, P. et al. (2019) âBlunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinsonâs diseaseâ, Nature Communications. Nature Publishing Group, 10(1). doi: 10.1038/s41467-019-11928-w.
- Kumagai, T. et al. âSex differences in the pharmacokinetics of levodopa in elderly patients with Parkinson disease.â, Clinical neuropharmacology, 37(6), pp. 173â6. doi: 10.1097/WNF.0000000000000051.
- Lee, H.-J. et al. (2010) âBrain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson disease.â, Neurochemical research, 35(4), pp. 613â9. doi: 10.1007/s11064-009-0106-6.
- Lee, J. et al. (2019) âSex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinsonâs diseaseâ, Proceedings of the National Academy of Sciences of the United States of America. National Academy of Sciences, 116(33), pp. 16577â16582. doi: 10.1073/pnas.1900406116.
- Leitner, G. R. et al. (2019) âTargeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disordersâ, Expert Opinion on Therapeutic Targets, 23(10), pp. 865â882. doi: 10.1080/14728222.2019.1676416.
- Liakh, I. et al. (2019) âModern Methods of Sample Preparation for the Analysis of Oxylipins in Biological Samples.â, Molecules (Basel, Switzerland). Multidisciplinary Digital Publishing Institute (MDPI), 24(8). doi: 10.3390/molecules24081639.
- Lucas, S. M., Rothwell, N. J. and Gibson, R. M. (2006) âThe role of inflammation in CNS injury and diseaseâ, British Journal of Pharmacology. Br J Pharmacol. doi: 10.1038/sj.bjp.0706400.
- Marriott, I. and Huet-Hudson, Y. M. (2006) âSexual dimorphism in innate immune responses to infectious organismsâ, Immunologic Research, pp. 177â192. doi: 10.1385/IR:34:3:177.
- Mattson, M. P. and Arumugam, T. V. (2018) âHallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic Statesâ, Cell Metabolism. Cell Press, pp. 1176â1199. doi: 10.1016/j.cmet.2018.05.011.
- McCarthy, M. M., Nugent, B. M. and Lenz, K. M. (2017) âNeuroimmunology and neuroepigenetics in the establishment of sex differences in the brainâ, Nature Reviews Neuroscience. Nature Publishing Group, pp. 471â484. doi: 10.1038/nrn.2017.61.
- McWilliams, T. G. et al. (2018) âBasal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demandâ, Cell Metabolism. Cell Press, 27(2), pp. 439-449.e5. doi: 10.1016/j.cmet.2017.12.008.
- Mirdamadi, J. L. (2016) âCerebellar Role in Parkinsonâs Disease.â, Journal of neurophysiology, p. jn.01132.2015. doi: 10.1152/jn.01132.2015.
- Mounsey, R. B. et al. (2015) âIncreasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinsonâs diseaseâ, Experimental Neurology, 273, pp. 36â44. doi: 10.1016/j.expneurol.2015.07.024.
- Newcombe, E. A. et al. (2018) âInflammation: The link between comorbidities, genetics, and Alzheimerâs disease 11 Medical and Health Sciences 1109 Neurosciences 11 Medical and Health Sciences 1107 Immunologyâ, Journal of Neuroinflammation. BioMed Central Ltd. doi: 10.1186/s12974-018-1313-3.
- Newman, L. E. and Shadel, G. S. (2018) âPink1/Parkin link inflammation, mitochondrial stress, and neurodegenerationâ, The Journal of cell biology. NLM (Medline), pp. 3327â3329. doi: 10.1083/jcb.201808118.
- Pace, S., Sautebin, L. and Werz, O. (2017) âSex-biased eicosanoid biology: Impact for sex differences in inflammation and consequences for pharmacotherapyâ, Biochemical Pharmacology. Elsevier Inc., pp. 1â11. doi: 10.1016/j.bcp.2017.06.128.
- Palmer, S. J. et al. (2010) âJoint amplitude and connectivity compensatory mechanisms in Parkinsonâs diseaseâ, Neuroscience, 166(4), pp. 1110â1118. doi: 10.1016/j.neuroscience.2010.01.012.
- Picillo, M. et al. (2017) âThe relevance of gender in Parkinsonâs disease: a reviewâ, Journal of Neurology, 264(8), pp. 1583â1607. doi: 10.1007/s00415-016-8384-9.
- Pochard, C. et al. (2018) âCyclooxygenase 2 is upregulated in the gastrointestinal tract in Parkinsonâs diseaseâ, Movement Disorders. John Wiley and Sons Inc., 33(3), pp. 493â494. doi: 10.1002/mds.27237.
- Rajamani, A. et al. (2019) âOxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat mealâ, Scientific Reports, 9(1), p. 8655. doi: 10.1038/s41598-019-45005-5.
- Ramsden, C. E. et al. (2016) âDietary linoleic acid-induced alterations in pro- and anti-nociceptive lipid autacoidsâ, Molecular Pain, 12, p. 174480691663638. doi: 10.1177/1744806916636386.
- Refolo, V. and Stefanova, N. (2019) âNeuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathiesâ, Frontiers in Cellular Neuroscience, 13, p. 263. doi: 10.3389/fncel.2019.00263.
- Richardson, D. et al. (2007) âQuantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry.â, Analytical biochemistry, 360(2), pp. 216â26. doi: 10.1016/j.ab.2006.10.039.
- Rieusset, J. (2018) âMitochondria-associated membranes (MAMs): An emerging platform connecting energy and immune sensing to metabolic flexibilityâ, Biochemical and Biophysical Research Communications, 500(1), pp. 35â44. doi: 10.1016/j.bbrc.2017.06.097.
- Scotland, R. S. et al. (2011) âSex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female miceâ, Blood, 118(22), pp. 5918â5927. doi: 10.1182/blood-2011-03-340281.
- Seidel, K. et al. (2017) âInvolvement of the cerebellum in Parkinson disease and dementia with Lewy bodiesâ, Annals of Neurology. John Wiley and Sons Inc., 81(6), pp. 898â903. doi: 10.1002/ana.24937.
- Shephard, F. et al. (2013) âA mitochondrial location for haemoglobins-Dynamic distribution in ageing and Parkinsonâs disease.â, Mitochondrion, 14(1), pp. 64â72. doi: 10.1016/j.mito.2013.12.001.
- Shephard, F. et al. (2014) âA mitochondrial location for haemoglobins--dynamic distribution in ageing and Parkinsonâs disease.â, Mitochondrion, 14(1), pp. 64â72. doi: 10.1016/j.mito.2013.12.001.
- Siani, F. et al. (2017) âInfluence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinsonâs Diseaseâ, Frontiers in Neuroscience, 11, p. 306. doi: 10.3389/fnins.2017.00306.
- Sigma-Aldrich (2013) âTechnical bulletin: Bradford Reagent B6916â, pp. 3â8.
- Sliter, D. A. et al. (2018a) âParkin and PINK1 mitigate STING-induced inflammationâ, Nature. doi: 10.1038/s41586-018-0448-9.
- Sliter, D. A. et al. (2018b) âParkin and PINK1 mitigate STING-induced inflammationâ, Nature. doi: 10.1038/s41586-018-0448-9.
- Smith, K. M. and Dahodwala, N. (2014) âSex differences in Parkinsonâs disease and other movement disorders.â, Experimental neurology, 259, pp. 44â56. doi: 10.1016/j.expneurol.2014.03.010.
- Stöger, R., Scaife, Paula J, et al. (2017) âElevated 5hmC levels characterize DNA of the cerebellum in Parkinsonâs disease.â, NPJ Parkinsonâs disease, 3, p. 6. doi: 10.1038/s41531-017-0007-3.
- Stöger, R., Scaife, Paula J., et al. (2017) âElevated 5hmC levels characterize DNA of the cerebellum in Parkinsonâs diseaseâ, npj Parkinsonâs Disease. Nature Publishing Group, 3(1), p. 6. doi: 10.1038/s41531-017-0007-3.
- Stojkovska, I., Wagner, B. M. and Morrison, B. E. (2015) âParkinsonâs disease and enhanced inflammatory responseâ, Experimental Biology and Medicine. SAGE Publications Inc., pp. 1387â1395. doi: 10.1177/1535370215576313.
- Vivekanantham, S. et al. (2015) âNeuroinflammation in Parkinsonâs disease: role in neurodegeneration and tissue repairâ, International Journal of Neuroscience, 125(10), pp. 717â725. doi: 10.3109/00207454.2014.982795.
- Weiduschat, N. et al. (2014) âSex differences in cerebral energy metabolism in Parkinsonâs disease: A phosphorus magnetic resonance spectroscopic imaging study.â, Parkinsonism & related disorders. doi: 10.1016/j.parkreldis.2014.02.003.
- Wong, A. et al. (2014) âSimultaneous tissue profiling of eicosanoid and endocannabinoid lipid families in a rat model of osteoarthritis.â, Journal of lipid research, 55(9), pp. 1902â13. doi: 10.1194/jlr.M048694.
- Wu, T. and Hallett, M. (2013) âThe cerebellum in Parkinsonâs disease.â, BrainâŻ: a journal of neurology, 136(Pt 3), pp. 696â709. doi: 10.1093/brain/aws360.
- Yoo, H. S. et al. (2019) âCerebellar connectivity in Parkinsonâs disease with levodopaâinduced dyskinesiaâ, Annals of Clinical and Translational Neurology, p. acn3.50918. doi: 10.1002/acn3.50918.
- Zhang, J. et al. (2015) âAkinetic-rigid and tremor-dominant Parkinsonâs disease patients show different patterns of intrinsic brain activity.â, Parkinsonism & related disorders, 21(1), pp. 23â30. doi: 10.1016/j.parkreldis.2014.10.017.
Preprints for Gentle Science
» MitoFit Preprints - the Open Access preprint server for mitochondrial physiology and bioenergetics
Labels: MiParea: mt-Medicine
Pathology: Parkinson's
Organism: Human